Effect of bronchial colonisation on airway and systemic inflammation in stable COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 2, 2012, Pages 121-130

  Marin, Alicia ^a,b,c   Garcia Aymerich, Judith ^d,e,f,g   Sauleda, Jaume ^c,h,i   Belda, Jose ^j   Millares, Laura ^a,b,c   García Núñez, Marian ^a,b,c   Serra, Ignasi ^d,e,g   Benet, Marta ^d,e,g   Agustí, Alvar ^c,i,k   Antó, Josep M ^d,e,f,g   Monsó, Eduard ^b,c,l  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁱ Fundació de Investigació Sanitaria de les Illes Balears ^*  (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l Hospital Universitari Parc Taul   (Spain)

more..

Author keywords

C reactive protein; Haemophilus influenzae; Health related quality of life; IL 1 ; IL 8

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BRONCHUS; BRONCHUS SECRETION; CELL COUNT; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; QUESTIONNAIRE; SMOKING; SPUTUM ANALYSIS;

AGED; BRONCHI; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SPIROMETRY; SPUTUM;

EID: 84859334307     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.636407     Document Type: Article

References (52)

1. Rosell A, Monso´ E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165:891-897. (Pubitemid 40563235)
2. Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129:317-324. (Pubitemid 43289850)
3. Marin A, Monsó E, Garcia-Nuñez M, et al. Variability and Effects of bronchial colonisation in patients with moderate COPD. Eur Respir J 2010; 35(2):295-302.
4. Gan WQ, Man SFP, SenthilselVan A, et al. Association between chronic obstructive pulmonary disease and systemic infl ammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-580. (Pubitemid 38901515)
5. Barnajee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway infl ammation and health status in clinical sable COPD. Eur Respir J 2004; 23:685-691. (Pubitemid 38618136)
6. Chin CL, Manzel LJ, Lehman EE, et al. Haemophilus infl uenzae from patients with chronic obstructive pulmonary disease exacerbation induce more infl ammation than colonizers. Am J Respir Crit Care Med 2005; 172:85-91. (Pubitemid 40923318)
7. Soler N, Ewig S, Torres A, et al. Airway infl ammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14:1015-1022.
8. Sethi S, Maloney J, Grove L, et al. Airway infl ammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 991-998.
9. Wilkinson T, Patel I, Wilks M, et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:1090-1095. (Pubitemid 36459654)
10. Hill A, Campbell EJ, Hill SL, et al. Association between airway bacterial load and markers of airway infl ammation in patients with stable chronic bronchitis. Am J Med 2000; 109:288-295.
11. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2010). http://www.goldcopd.org (accessed 08 June 2011).
12. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946. (Pubitemid 38807371)
13. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of diff erent forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317:1309-1314. (Pubitemid 17153012)
14. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:467-470.
15. Wegner RE, Jorres RA, Kirsten DK, et al. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7:725-729. (Pubitemid 24122970)
16. Fuchs-Climent D, Le Gallais D, Varray A, et al. Factor analysis of quality of life dyspnea, and physiologic variables in patients with chronic obstructive pulmonary disease before and after rehabilitation. Am J Phys Med Rehabil 2001; 80:113-120. (Pubitemid 32121613)
17. Weatherall M, Shirtcliff e P, Travers J, et al. Use of cluster analysis to defi ne COPD phenotypes. Eur Respir J 2010; 36:472-474.
18. Burgel PR, Paillaseul JL, Caillaud D, et al. Clinical phenoptypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36:531-539.
19. Garcia-Aymerich J, Gomez FP, Benet M, et al. Identifi cation and prospective validation of clinically releVant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437.
20. Balcells E, Antó JM, Gea J, et al. Characteristics of patients admitted for the fi rst time for COPD exacerbation. Respir Med 2009; 103:1293-302.
21. Garcia-Aymerich J, Gómez FP, Antó JM; en nombre del Grupo Investigador del Estudio PAC-COPD. Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods. Arch Bronconeumol 2009; 45(1):4-11.
22. Fujimoto K, Kubo K, Yamamoto H, et al. Eosinophilic infl ammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999; 115:697-702. (Pubitemid 29129947)
23. Pin I, Gibson PG, Kolendowicz R, et al. Use induced sputum cell counts to investigate airway infl ammation in asthma. Thorax 1992;47:25-29.
24. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway infl ammation in induced sputum: reproducibility and validity of cell and fl uid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317. (Pubitemid 26269096)
25. Sutherland ER, Pak J, Langmack EL, et al. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002; 96:482-6.
26. Efthimiadis A, Jayaram L, Weston S, et al. Induced sputum: time from expectoration to processing. Eur Respir J 2002; 19:706-708. (Pubitemid 34285168)
27. Aaron SD, Angel JB, Lunau M, et al. Granulocyte infl ammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:349-355. (Pubitemid 32158511)
28. Pye A, Stockley RA, Hill SL. Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol 1995; 48:719-724.
29. Balows A, Hausler WJ, Herrmann KL, et al. Manual of Clinical Microbiology, 5Thed. Washington DC, American Society of Microbiology, 1991.
30. Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997; 10:1137-1144. (Pubitemid 27201822)
31. Sethi S, Sethi R, Eschberger K, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176:356-361. (Pubitemid 47267469)
32. Middleton AM, Dowling RB, Mitchell JL, et al. Haemophilus parainfl uenzae infection of respiratory mucosa. Respir Med 2003; 97:375-381. (Pubitemid 36410605)
33. Sethi S, Muscarella K, EVans N, et al. Airway infl ammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118:1557-1565. (Pubitemid 32001777)
34. Man SFP, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61:849-853. (Pubitemid 44570304)
35. Bathoorn E, Liesker JJW, Postma D, et al. Change in infl ammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J COPD 2009; 4:101-109.
36. Hloz O, Kips J, Magnussen H. Update on sputum methodology. Eur Respir J 2000; 16:355-359. (Pubitemid 30624957)
37. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155:449-453. (Pubitemid 27085784)
38. Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic infl ammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92:537-548. (Pubitemid 23317079)
39. Balzano G, Stefanelli F, Iorio C, et al. Eosinophilic infl ammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999; 160:1486-1492.
40. Snoeck-Stroband JB, Lapperre TS, Gosman MM, et al. Chronic bronchitis sub-phenotype within COPD: infl ammation in sputum and biopsies. Eur Respir J 2008 Jan; 31:70-77.
41. Bhowmik A, Seemugal TAR, Sapsford RJ, et al. Relation of sputum infl ammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114-120. (Pubitemid 30245950)
42. Keatings VM, Collins PD, Scott DM, et al. Diff erences in interleukin-8 and tumor necrosis factor-alfa in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534.
43. Richman-Eisenstat JB, Jorens PG, Hebert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic infl ammatory airway diseases. Am J Physiol 1993; 264:L413-418. (Pubitemid 23125320)
44. Berenson CS, Murphy TF, Wrona CT, et al. Outer membrane protein P6 of nontypeable Haemophilus infl uenzae is a potent and selective inducer of human macrophage proinfl ammatory cytokines. Infection and Immunity 2005; 73:2728-2735. (Pubitemid 40570338)
45. Bresser P, Out TA, VanAlphen L, et al. Airway infl ammation in nonobstuctive and obstructive chronic bronchitis with Haemophilus infl uenzae airway infection. Am J Respir Crit Care Med 2000; 162:947-952.
46. Zhang M, Li Q, Zhang XY, et al. ReleVance of lower airway bacterial colonization, airway infl ammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis 2010; 29:1487-1493.
47. Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal 2010 Jan 19; 3 (105):cm2. Review.
48. Miravitlles M, Marín A, Monsó, et al. Colour of sputum is a marker of bacterial colonisation in chronic obstructive pulmonary disease. Respir Res 2010; 11:58.
49. Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:867-874. (Pubitemid 44564786)
50. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007; 131:1058-1067. (Pubitemid 46608707)
51. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive disease are accompanied by elevations of plasma fi brinogen and serum IL-6 levels. Thromb Haemost 2000; 84:210-215. (Pubitemid 30601465)
52. Dahl M, Vetsbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250-255. (Pubitemid 46203128)